Therefore, we investigated in an experimental model of DCM, the ZDF rat [8,29] the effects of fenofibrate, a PPARα agonist used in the treatment of hypertriglyceridemia [24], on two main manifestations of DCM, TAG accumulation and fibrosis in LV. The gene discussed is PPARA; the disease is familial dilated cardiomyopathy.